A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Public ClinicalTrials.gov record NCT05303467. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
FRONTIER: A Feasibility Study to Evaluate the Safety of the TheRaSphere GliOblastoma (GBM) Device iN PaTIEnts With Recurrent GBM
Study identification
- NCT ID
- NCT05303467
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Interventions
- TheraSphere GBM Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 29, 2022
- Primary completion
- Jul 30, 2026
- Completion
- Jan 30, 2027
- Last update posted
- Apr 28, 2026
2022 – 2027
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Birmingham | Birmingham | Alabama | 35294 | Withdrawn |
| University of California San Diego | San Diego | California | 92103 | Not yet recruiting |
| University of California San Francisco | San Francisco | California | 94143 | Recruiting |
| Mayo Jacksonville | Jacksonville | Florida | 32224 | Recruiting |
| Northwestern Univerity | Chicago | Illinois | 60611 | Recruiting |
| Johns Hopkins Interventional Radiology Center | Baltimore | Maryland | 21287 | Withdrawn |
| Washington University School of Medicine | St Louis | Missouri | 63130 | Recruiting |
| Lenox Hill Hospital | New York | New York | 10075 | Recruiting |
| MD Anderson Cancer Center | Houston | Texas | 77030 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05303467, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05303467 live on ClinicalTrials.gov.